Corient Private Wealth
EOLS icon

Corient Private Wealth’s Evolus EOLS Stock Holding History

Corient Private Wealth’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$437K Sell
63,003
-16,936
-21% -$100K ﹤0.01% 2323
2026
Q1 		$329K Buy
+79,939
New +$387K ﹤0.01% 2271

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Corient Private Wealth's EOLS Position: Q2 2026 in Review

Corient Private Wealth reduced its Evolus (EOLS) stake by 21% in Q2 2026, selling an estimated $100K and leaving 63,003 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

Corient Private Wealth first reported a position in EOLS in Q1 2026 and has held it in 2 quarters since. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Corient Private Wealth held 63,003 shares of Evolus worth $437K as of Q2 2026.
  • Corient Private Wealth sold 16,936 Evolus shares in Q2 2026, an estimated $100K.
  • Evolus made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2323 holding.
  • Corient Private Wealth first reported a position in Evolus in Q1 2026 and has held it in 2 quarters since.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.